RecruitingPhase 4NCT07112339

A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes

Studying MODY

Last synced from ClinicalTrials.gov May 13, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Novo Nordisk A/S
Principal Investigator: Clinical Transparency (dept. 2834)
Novo Nordisk A/S
Intervention: Insulin icodec(drug)
Enrollment: 586 target
Eligibility: 18 years · All sexes
Timeline: 2025 – 2028

Study locations (30)

Centricity Research Calgary Endocrinology, Calgary, Alberta, Canada
Alta Clinical Research at Hermitage Medicentre, Edmonton, Alberta, Canada
Fraser Clinical Trials Inc., New Westminster, British Columbia, Canada
Winnipeg Clinic, Winnipeg, Manitoba, Canada
G.A. Research Associates Ltd., Moncton, New Brunswick, Canada
Centricity Research Brampton Endocrinology, Brampton, Ontario, Canada
Centricity Clinical Research Burlington, Burlington, Ontario, Canada
Centricity Research Vaughn Endocrinology, Concord, Ontario, Canada
Medical Trust Clinics, Inc., Courtice, Ontario, Canada
Centricity Research Etobicoke Endocrinology, Etobicoke, Ontario, Canada
Janik Research, Greater Sudbury, Ontario, Canada
Premier Clinical Trial Research Network (PCTRN), Hamilton, Ontario, Canada
St. Josephs Health Care, London, Ontario, Canada
Western Univ. Cnt for Studies in Fam Med, London, Ontario, Canada
Malton Medical Clinic, Mississauga, Ontario, Canada
+15 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07112339 on ClinicalTrials.gov

Other trials for MODY

Additional recruiting or active studies for the same condition.

See all trials for MODY →

← Back to all trials